CII Elects Rajiv Memani As New President For 2025-26

New Delhi: The Confederation of Indian Industry (CII) on Sunday elected new place of business bearers for the 12 months 2025-26 and Rajiv Memani, Chairman and CEO of EY India, has assumed place of business because the CII President. He takes over from Sanjiv Puri, Chairman and Managing Director of ITC Ltd, the apex trade chamber stated in a observation.

Memani may be a member of EY Global Executive Board because the Chair of its Growth Markets Council. He is a relied on guide to huge Indian firms, non-public fairness finances and multinational organisations, mainly advising them on development self assurance, mergers and acquisitions, generation and sensible capital allocation methods.

In his Emerging Markets (EM) position, his tasks come with advancing EY’s rising markets enlargement time table and connecting their priorities with the worldwide company’s investments.

Prior to turning into the Chairman and CEO, Memani established EY India’s market-leading Corporate Finance (now Strategy & Transactions) apply within the past due 90s. He used to be additionally the President-Designate of the Confederation of Indian Industry for the 12 months 2024-25 and Vice President for the 12 months 2023-24.

R Mukundan, Managing Director and CEO of Tata Chemicals Limited takes over as CII’s President-Designate for 2025-26, stated the apex industry chamber. Mukundan joined Tata Administrative Service in 1990, after final touch of MBA from FMS, Delhi University. He is a outstanding alumnus of IIT, Roorkee; Fellow of Indian Chemical Society and an alumnus of Harvard Business School.

Dr Suchitra Okay Ella, Co-founder and Managing Director, Bharat Biotech International Limited takes over as CII Vice President for 2025-26. She used to be instrumental in founding Bharat Biotech long ago in 1996.

In the previous decade, Dr (Mrs) Ella has co-founded and nurtured a number of firms in veterinary sciences, agri-biotech parks, meals processing together with pre-clinical toxicology and analysis institute, in keeping with the CII observation.